Company / Accounts Receivable
BIOMERICA INC Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$731.0K
FY2025
5-year range
$722.0K / $1.5M
FY2021-FY2025
Trend
-22.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $722,000 in FY2023 to $2M in FY2020.
Based on SEC 10-K filings.
$731,000 in FY2025 with a 5-year CAGR of -16.2%.
Remained stable around $731,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- -16.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.2%, indicating a declining trend.
- In FY2025, accounts receivable decreased 22.8% year-over-year.
- Peak accounts receivable was recorded in FY2020.
- Lowest accounts receivable in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $731.0K | -22.8% |
| FY2024 | $947.0K | +31.2% |
| FY2023 | $722.0K | -6.7% |
| FY2022 | $774.0K | -46.8% |
| FY2021 | $1.5M | -17.6% |
| FY2020 | $1.8M | +21.4% |
| FY2019 | $1.5M | +81.8% |
| FY2018 | $799.9K | -24.5% |
| FY2017 | $1.1M | +9.3% |
| FY2016 | $969.5K | -12.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026